Drug Development Grant (Alzheimer’s Disease worldwide)
The Drug Development Grant from the Alzheimer´s Drug Discovery Foundation provides funding to support in vivo clinical studies that would lead to a compound with a strong potential for clinical and commercial application in the treatment of Alzheimer’s disease. The grant is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. Applicants may apply for up to 600,000 USD (direct costs only) for 1 year with the potential for renewal. There are three assessment rounds per year and the next letter of intent deadline is September 30, 2022 and full applications are due on December 2, 2022.
Challenge: Brain Conditions
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.